- Dubai a 'Wake Up Call'—Expect Volatility Now: Market Pro
- We're Approaching a Market Bubble: Portfolio Manager
- Hershey Shares: What Options Are Saying
- Best Online Retailers to Buy Now: Internet Analyst
- Dubai Fear is 'Noise'—Stay Fully Invested: Strategist
- Buy or Hold: Analyst Rates 10 Retail Stocks
- My Commodities Outlook after Dubai: Dennis Gartman
- Portfolio Prep for Next Week: 'Don't Get Crazy'
- Strategists on Dubai: Avoid 'Rash Moves' Now
- Dubai Stock Market Fear Has 'Legs': Dennis Gartman
MOST SHARED
- Timeless and Time-Tested Warren Buffett Watch Predictions
- Should Homeowners Be Able To Walk Away From Mortgage?
- Goldman Sachs Party Ban: No Gatherings of 12 or More
- Dubai World Set to Restructure About $26 Billion of Total Debt
- Governments Must Take Steps To Avoid More Dubais: El-Erian
- Black Friday Sales Disappoint Investors; Amazon Up
- Nov. 30: Unusual Volume Leaders
- Blue Nile CEO: 'We're Having the Best Cyber Monday Ever'
- Notre Dame Fires Charlie Weis After 5 Seasons
- Get Paid Six Figures to Wear a T-Shirt?
- Treasury Threatens Banks, Not Borrowers
- We're Approaching a Market Bubble: Portfolio Manager
- Hershey Shares: What Options Are Saying
- Nov. 30: Unusual Volume Leaders
- Why Careful Shoppers Are Great for the Box Office
- Blue Nile CEO: 'We're Having the Best Cyber Monday Ever'
- Best Online Retailers to Buy Now: Internet Analyst
- ESPN The Magazine’s Body Issue: A Financial Success
- Cyber Monday: The Last Vestige of Dotcom Hype
- Treasury Threatens Banks, Not Borrowers
- Dubai World to Restructure About $26 Billion of Debt
- Lesson From Dubai: Start Cutting Risk In Your Portfolio
- Iranian Seizure of British Yacht Pushes Oil Above $77
- Should Homeowners Be Able to Stop Paying Mortgage?
- Buffett's Predictions For Next Year—And Every Year
- The World's Biggest Debtor Nations
- Scientists Gone Wild: Climate Debate Turns Nasty
- Goldman Sachs Party Ban: No Gatherings of 12 or More
RSS FEED
CNBC Stock Blog
Text Size 
The iShares Nasdaq Biotechnology exchange-traded fund is drawing strong options activity Thursday, as news ranging from mergers to government regulation continues to rock the sector.
More than 4,000 calls were bought for $0.35 at the April 70 strike in the first 90 minutes of trading this morning, four times the open interest, according to OptionMonster's tracking systems. The buying has extended to the June 70 calls as well.
Shares of the IBB ETF [IBB
Loading...
()
] are up more than 4 percent in midday trading to $62.90, near the highs of the day but still some 30 percent below their 52-week peak. The index has been on a roller-coaster ride for months, rising with M&A activity and falling with the threat of increased regulatory controls of the industry along with the pharmaceuticals sector.
Just today, Gilead Sciences [GILD
Loading...
()
] announced its intention to acquire CV Therapeutics for $1.4 billion, a deal involving two companies in the IBB. Gilead is the ETF's second-largest holding, with an index weighting of 9.7 percent.
______________________________
More Biotech in the News:
Genentech [DNA
Loading...
()
]
Amgen [AMGN
Loading...
()
]
Biogen Idec [BIIB
Loading...
()
]
______________________________
Pete Najarian is a professional investor, CNBC contributor, regular co-host of CNBC's "Fast Money" and co-founder of OptionMonster.com.
______________________________
Data is a real-time snapshot *Data is delayed at least 15 minutes